| BRIEF COMMUNICATION |
|
| Year : 2022 | Volume
: 10
| Issue : 2 | Page : 85-87 |
|
|
Central serous chorioretinopathy in coronavirus disease-19 patient
Shipra Singh, JL Goyal, Divya Singh
Department of Ophthalmology, School of Medical Sciences and Research, Sharda University, Greater Noida, Uttar Pradesh, India
Correspondence Address:
Shipra Singh
H-1201, Cloud 9 Towers, Sector 3F, Kamma 1, Vaishali, Ghaziabad - 201 019, Uttar Pradesh
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jcor.jcor_80_21
|
|
|
A 46-year-old male with mild coronavirus disease 2019 (COVID-19) symptoms presented to the emergency department complaining of decreased vision in the right eye (RE). Funduscopic examination revealed serous macular detachment at the posterior pole with loss of foveal reflex in the RE. Fundus fluorescein angiography revealed pinpoint leakage in the early phase, which was enlarged in the late phase to appear like inkblot suggestive of central serous chorioretinopathy (CSCR), which was confirmed on optical coherence tomography as hyporeflective space due to the collection of serous fluid between the neurosensory retina and retinal pigment epithelium. He received COVID-19 directed therapy. The patient became systemically alright and his vision in the RE improved. Severe acute respiratory syndrome coronavirus 2 is associated with thromboembolic events and retinal ischemia may create hyperpermeability of choroid leading to the formation of CSCR.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
